Search Results for: TP53

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel NR3C1 nuclear receptor subfamily 3 group C member 1
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • SUMOylation of intracellular receptors
  • PTK6 Expression
  • Regulation of RUNX2 expression and activity
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Potential therapeutics for SARS
  • Regulation of NPAS4 gene transcription
  • Flunisolide
  • Diflorasone
  • Alclometasone
  • Medrysone
  • Amcinonide
  • Fluorometholone
  • Megestrol acetate
  • Levonorgestrel
  • Beclomethasone dipropionate
  • Progesterone
  • Spironolactone
  • Betamethasone
  • Desoximetasone
  • Fluticasone propionate
  • Fluocinolone acetonide
  • Ulobetasol
  • Triamcinolone
  • Prednisone
  • Flumethasone
  • Fludrocortisone
  • Norethisterone
  • Hydrocortisone
  • Mometasone
  • Hydrocortamate
  • Mifepristone
  • Clocortolone
  • Flurandrenolide
  • Prednisolone
  • Loteprednol etabonate
  • Rimexolone
  • Methylprednisolone
  • Clobetasol propionate
  • Fluocinonide
  • Prednicarbate
  • Fluoxymesterone
  • Budesonide
  • Dexamethasone
  • Desonide
  • Cortisone acetate
  • Paramethasone
  • Drospirenone
  • Ciclesonide
  • Hexane-1,6-Diol
  • Aldosterone
  • ORG-34517
  • Difluprednate
  • Ulipristal
  • Fluticasone furoate
  • Tixocortol
  • Difluocortolone
  • Gestrinone
  • Deflazacort
  • Onapristone
  • Cortivazol
  • Clobetasone
  • Fluticasone
  • Mometasone furoate
  • Hydrocortisone aceponate
  • Hydrocortisone acetate
  • Hydrocortisone butyrate
  • Hydrocortisone cypionate
  • Hydrocortisone phosphate
  • Hydrocortisone probutate
  • Hydrocortisone valerate
  • Segesterone acetate
  • Prednisolone phosphate
  • Dexamethasone acetate
  • Betamethasone phosphate
  • Prednisolone acetate
  • 46,XX disorders of sex development (Disorders related to androgen excess), including: Congenital adrenal hyperplasias; Glucocorticoid resistance; Aromatase deficiency
Novel NR4A1 nuclear receptor subfamily 4 group A member 1
  • AKT phosphorylates targets in the nucleus
  • Nuclear Receptor transcription pathway
  • Constitutive Signaling by AKT1 E17K in Cancer
Novel NRON non-coding repressor of NFAT
Novel NSD2 nuclear receptor binding SET domain protein 2
  • PKMTs methylate histone lysines
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Nonhomologous End-Joining (NHEJ)
  • Processing of DNA double-strand break ends
  • G2/M DNA damage checkpoint
  • Multiple myeloma
Novel NTHL1 nth like DNA glycosylase 1
  • Recognition and association of DNA glycosylase with site containing an affected pyrimidine
  • Cleavage of the damaged pyrimidine
  • Displacement of DNA glycosylase by APEX1
  • Defective NTHL1 substrate processing
  • Defective NTHL1 substrate binding
Novel OGT O-linked N-acetylglucosamine (GlcNAc) transferase
  • HATs acetylate histones
  • RIPK1-mediated regulated necrosis
  • Regulation of necroptotic cell death
  • UCH proteinases
  • Formation of WDR5-containing histone-modifying complexes
Novel OTUB1 OTU deubiquitinase, ubiquitin aldehyde binding 1
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
Novel OTUD3 OTU deubiquitinase 3
  • Ovarian tumor domain proteases
  • Regulation of PTEN stability and activity
Novel OTUD5 OTU deubiquitinase 5
  • Ovarian tumor domain proteases
  • Negative regulators of DDX58/IFIH1 signaling
Novel PADI1 peptidyl arginine deiminase 1
  • Chromatin modifying enzymes
  • Citrulline
Novel PAFAH1B3 platelet activating factor acetylhydrolase 1b catalytic subunit 3
  • COPI-independent Golgi-to-ER retrograde traffic
  • (1R)-1,2,2-trimethylpropyl (R)-methylphosphinate
Novel PARP1 poly(ADP-ribose) polymerase 1
  • POLB-Dependent Long Patch Base Excision Repair
  • vRNA Synthesis
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SUMOylation of DNA damage response and repair proteins
  • HDR through MMEJ (alt-NHEJ)
  • DNA Damage Recognition in GG-NER
  • Formation of Incision Complex in GG-NER
  • Dual Incision in GG-NER
  • Theophylline
  • Zinc
  • Carba-nicotinamide-adenine-dinucleotide
  • NU1025
  • Nicotinamide
  • 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone
  • 3-Methoxybenzamide
  • 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
  • 3,4-Dihydro-5-Methyl-Isoquinolinone
  • 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide
  • 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE
  • Veliparib
  • A-620223
  • 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE
  • Olaparib
  • Talazoparib
  • Niraparib
  • Rucaparib
  • Iniparib
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
Novel PBK PDZ binding kinase
Novel PCDHA4 protocadherin alpha 4
Novel PDGFRA platelet derived growth factor receptor alpha
  • PIP3 activates AKT signaling
  • Downstream signal transduction
  • Signaling by PDGF
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Imatinib-resistant PDGFR mutants
  • Sunitinib-resistant PDGFR mutants
  • Regorafenib-resistant PDGFR mutants
  • Sorafenib-resistant PDGFR mutants
  • PDGFR mutants bind TKIs
  • Becaplermin
  • Imatinib
  • Sunitinib
  • XL820
  • Olaratumab
  • Pazopanib
  • Midostaurin
  • Regorafenib
  • Ponatinib
  • Lenvatinib
  • Nintedanib
  • Foreskin keratinocyte (neonatal)
  • Tivozanib
  • Fostamatinib
  • Erdafitinib
  • Amuvatinib
  • Ripretinib
  • Glioma
Novel PDLIM7 PDZ and LIM domain 7
  • RET signaling
Novel PELI1 pellino E3 ubiquitin protein ligase 1
  • Regulation of necroptotic cell death
  • Interleukin-1 signaling
  • IRAK1 recruits IKK complex
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
Novel PELI2 pellino E3 ubiquitin protein ligase family member 2
  • Interleukin-1 signaling
  • IRAK1 recruits IKK complex
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
Novel PELP1 proline, glutamate and leucine rich protein 1
  • Major pathway of rRNA processing in the nucleolus and cytosol
  • PTK6 Expression
Novel PER2 period circadian regulator 2
  • Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes
  • The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex
  • Phosphorylation and nuclear translocation of the CRY:PER:kinase complex
  • Degradation of CRY and PER proteins
  • Degradation of CRY and PER proteins
  • Familial advanced sleep phase syndrome

Page 15 out of 52 pages